The 1st glutathione-interaction site, also termed glutathione-scaffold site, is rather well defined and comprises several protein areas that altogether contribute to catalysis by interacting with the glutathione moiety of GSSR 7,8,13,14,15,35 , therefore explaining the specificity for the -glutamyl moiety 9,49,50
IV therapy ensures 100% bioavailability, bypassing digestive degradation
Beyond physiological monitoring, AI contributes to therapeutic adaptation by analyzing longitudinal clinical data, such as genetic markers, patient histories, and immune profiles [244]
Hepatic ischemia-reperfusion impairs blood-brain barrier partly due to release of arginase from injured liver